Diligence memo · auto-generated · as of July 2, 2026
Axogen Corp
Axogen Corp looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Axogen Corp operates in Biotechnology, based in ALACHUA.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Axogen Corp has raised $14M in disclosed capital across 6 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.7M on 2010-06-11.
Most recent recorded round closed around 2011-05-03.
Valuation (modeled)modeled
Provath models Axogen Corp at approximately $133M (range $2.2M–$1.0B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.54× the median modeled value of Seed Biotechnology companies in 2010–2012 (151 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 4 months.
Last raise 15.2 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 6.0× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 62% of Biotechnology peers (4293 compared).
Modeled value ranks above 64% of those peers.
Closest niche peers: Denali Medical II, Inc., Signum Biosciences, Inc., Health Elements, LLC, Nkt Therapeutics Inc, Surface Logix Inc.
Peoplefiled
20 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.